MLchartDataset catalogue

LipoTaxen

Term · Oncology and biomedicine · MLC-T-ONC-004867

A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LipoTaxen blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called LEP-ETU, liposomal paclitaxel, paclitaxel liposome, and PNU-93914.

Table 1. Record
IdentifierMLC-T-ONC-004867
FieldOncology and biomedicine
SynonymsLEP-ETU; liposomal paclitaxel; paclitaxel liposome; PNU-93914
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004867",
  "term": "LipoTaxen",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LipoTaxen blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called LEP-ETU, liposomal paclitaxel, paclitaxel liposome, and PNU-93914.",
  "synonyms": [
    "LEP-ETU",
    "liposomal paclitaxel",
    "paclitaxel liposome",
    "PNU-93914"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/lipotaxen/"
}

Record 10,198 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.